About Matthew Scholz
Form D filings for Oisin Biotechnologies from 2020 to 2024 list Matthew Scholz as president & CEO, director.
Matthew Scholz first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Scholz in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Scholz works with at each company, as listed on that company's latest Form D.
Oisin Biotechnologies, Inc. · Form D, Jul 12, 2024
EG
Eric Garcia
Executive officer
DG
David Gobel
Director
SH
Stephen Hilbert
Executive officer
JL
John Lewis
Executive officer
GH
Gary Hudson
Executive officer and director
DQ
Danjuma Quarless
Director